[1] Feng P, Fan WJ, Liu L, et al. Inhibitory effect of recombinant human semaphorin 3A on angiogenesis of gastric cancer and the associated mechanisms[J]. Acta Anatomica Sinica, 2020,51(2):11-13. (in Chinese)
冯品, 范文静, 刘镭,等. 重组人信号素3A抑制胃癌血管生成及其机制[J]. 解剖学报, 2020,51(2):11-13.
[2] Cai R, Zhu Y, Wang KF, et al. Effect of melatonin on the expression of Th1/Th2/Th17 cytokines of gastric cancer in vitro and in vivo[J]. Acta Anatomica Sinica, 2019, 50(4):471-476. (in Chinese)
蔡蓉, 朱瑜, 王开放,等. 褪黑素体内外对胃癌Th1/Th2/Th17型细胞因子表达的影响[J]. 解剖学报, 2019, 50(4):471-476.
[3] Ji L, Selleck MJ, Morgan JW,et al.Gastric cancer peritoneal carcinomatosis risk score[J]. Ann Surg Oncol, 2020, 27(1): 240-247.
[4] Lena F, Sarah TH, Daniel S, et al. MicroRNA profiles of MS grary matter lesions identify modulators of the synaptic protein synaptotagmin-7[J]. Brain Pathol, 2020, 30(3): 524-540.
[5] Banihashemi S, Tahmasebi-Birgani M, Mohammadiasl J, et al. Whole exome sequencing identified a novel nonsense INPP4A mutation in a family with intellectual disability[J]. Eur J Med Genet, 2020, 63(4):103846-103850.
[6] Aki S, Yoshioka K, Takuwa N, et al. TGFβ receptor endocytosis and Smad signaling require synaptojanin1, PI3K-C2α, and INPP4Bmediated phosphoinositide conversions[J]. Mol Biol Cell, 2020, 31(5):360-372.
[7] Guo HY, Gao Y, Zhang ChJ, et al. Correlation between serum miR-4286 expression and clinicopathological characteristics of gastric cancer and its clinical significance[J]. China Journal of Modern Medicine, 2019, 29(10):33-38. (in Chinese)
郭红艳, 高勇, 张春晶, 等. 血清microRNA-4286表达与胃癌临床病理特征的关系及其临床意义[J]. 中国现代医学杂志, 2019, 29(10):33-38.
[8] Zhang M, Tian H, Li R, et al. MicroRNA-4286 promotes esophageal carcinoma development by targeting INPP4A to evoke the JAK2/STAT3 pathway activation[J]. Pharmazie,2018,73(6):342-348.
[9] Chen X, Yu XT, Shen E. Overexpression of CDKN2B is involved in poor gastric cancer prognosis[J]. J Cell Biochem, 2019,120(12):19825-19831.
[10] Lederer WH, Gerstbrein HL. Creatine kinase isoenzyme BB activity in serum of a patient with gastric cancer[J]. Clin Chem,1976,22(10):1748-1749.
[11] Witwer KW. Circulating microRNA biomarker studies: pitfalls and potential solutions[J]. Clin Chem,2015,61(1):56-63.
[12] Hoon BJ, Qing Z, Feng L, et al. The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva[J]. Clin Chem,2015,61(1):221-230.
[13] Lena F, Sarah TH, Daniel S, et al. MicroRNA profiles of MS gray matter lesions identify modulators of the synaptic protein synaptotagmin-7[J]. Brain pathol, 2020,30(3):524-540.
[14] Ling C, Wang X, Zhu J, et al. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer[J]. Cancer Med, 2019, 8(7):3520-3531.
[15] Anna K, Nadezhda P, Mariya A, et al. Antiproliferative and Pro-apoptotic effects of miR-4286 inhibition in melanoma cells[J]. PLoS One, 2016, 11(12):e0168229.
[16] Sung JY, Na K, Kim HS. Down-regulation of inositol polyphosphate 4-phosphatase type Ⅱ expression in colorectal carcinoma[J]. Anticancer Res, 2017, 37(10):5525-5531.
[17] Wang H, Loerke D, Bruns C, et al. Phosphatidylinositol 3,4-bisphosphate synthesis and turnover are spatially segregated in the endocytic pathway[J]. J Biol Chem, 2020, 295(4):1091-1104.
|